Expert Insight
Thermo Fisher Deploys OpenAI Following Three-Year AI Strategy While 80% of CDMOs Remain in Pilot Phase
Thermo Fisher Scientific has announced it will integrate OpenAI’s artificial intelligence models across its clinical research and manufacturing operations, marking the execution phase of an AI strategy that began three years ago. The partnership embeds AI-powered tools into workflows spanning
23 October 2025